These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32214228)

  • 1. Gene therapy regulation: could in-body editing fall through the net?
    Mourby M; Morrison M
    Eur J Hum Genet; 2020 Jul; 28(7):979-981. PubMed ID: 32214228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What would responsible remedial human germline editing look like?
    Adashi EY; Cohen IG
    Nat Biotechnol; 2020 Apr; 38(4):398-400. PubMed ID: 32214241
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany.
    Renner M; Anliker B; Sanzenbacher R; Schuele S
    Adv Exp Med Biol; 2015; 871():87-101. PubMed ID: 26374214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Washington summit: orange light for genome editing?].
    Jordan B
    Med Sci (Paris); 2016 Feb; 32(2):217-20. PubMed ID: 26936181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive resource on EU regulatory information for investigators in gene therapy clinical research and advanced therapy medicinal products.
    Cohen-Haguenauer O
    Hum Gene Ther; 2013 Jan; 24(1):12-8. PubMed ID: 23339285
    [No Abstract]   [Full Text] [Related]  

  • 6. Why Include the Public in Genome Editing Governance Deliberation?
    Blasimme A
    AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morality and ethics governing CRISPR-Cas9 patents in China.
    Peng Y
    Nat Biotechnol; 2016 Jun; 34(6):616-8. PubMed ID: 27281418
    [No Abstract]   [Full Text] [Related]  

  • 8. Editing EU legislation to fit plant genome editing: The use of genome editing technologies in plant breeding requires a novel regulatory approach for new plant varieties that involves farmers.
    Ricroch AE; Ammann K; Kuntz M
    EMBO Rep; 2016 Oct; 17(10):1365-1369. PubMed ID: 27629042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges with advanced therapy medicinal products and how to meet them.
    ; ; Schneider CK; Salmikangas P; Jilma B; Flamion B; Todorova LR; Paphitou A; Haunerova I; Maimets T; Trouvin JH; Flory E; Tsiftsoglou A; Sarkadi B; Gudmundsson K; O'Donovan M; Migliaccio G; Ancāns J; Maciulaitis R; Robert JL; Samuel A; Ovelgönne JH; Hystad M; Fal AM; Lima BS; Moraru AS; Turcáni P; Zorec R; Ruiz S; Akerblom L; Narayanan G; Kent A; Bignami F; Dickson JG; Niederwieser D; Figuerola-Santos MA; Reischl IG; Beuneu C; Georgiev R; Vassiliou M; Pychova A; Clausen M; Methuen T; Lucas S; Schüssler-Lenz M; Kokkas V; Buzás Z; MacAleenan N; Galli MC; Linē A; Gulbinovic J; Berchem G; Fraczek M; Menezes-Ferreira M; Vilceanu N; Hrubisko M; Marinko P; Timón M; Cheng W; Crosbie GA; Meade N; di Paola ML; VandenDriessche T; Ljungman P; D'Apote L; Oliver-Diaz O; Büttel I; Celis P
    Nat Rev Drug Discov; 2010 Mar; 9(3):195-201. PubMed ID: 20190786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should the applications of genome editing be assessed and regulated?
    Fears R; Ter Meulen V
    Elife; 2017 Apr; 6():. PubMed ID: 28375079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating the gene-therapy revolution.
    Bender E
    Nature; 2018 Dec; 564(7735):S20-S22. PubMed ID: 30542185
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene editing in legal limbo in Europe.
    Nature; 2017 Feb; 542(7642):392. PubMed ID: 28230148
    [No Abstract]   [Full Text] [Related]  

  • 13. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
    Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
    Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encountering Challenges with the EU Regulation on Advance Therapy Medical Products.
    Mansnérus J
    Eur J Health Law; 2015 Dec; 22(5):426-61. PubMed ID: 26665690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan.
    Halioua-Haubold CL; Peyer JG; Smith JA; Arshad Z; Scholz M; Brindley DA; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):683-693. PubMed ID: 29259533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European hospital exemption clause-new option for gene therapy?
    Buchholz CJ; Sanzenbacher R; Schüle S
    Hum Gene Ther; 2012 Jan; 23(1):7-12. PubMed ID: 22247961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EU Court of Justice extends the GMO Directive to gene-edited organisms.
    Ruffell D
    FEBS Lett; 2018 Nov; 592(22):3653-3657. PubMed ID: 30426476
    [No Abstract]   [Full Text] [Related]  

  • 18. Use the patent system to regulate gene editing.
    Parthasarathy S
    Nature; 2018 Oct; 562(7728):486-488. PubMed ID: 30353159
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical development of gene therapy needs a tailored approach: a regulatory perspective from the European Union.
    Narayanan G; Cossu G; Galli MC; Flory E; Ovelgonne H; Salmikangas P; Schneider CK; Trouvin JH
    Hum Gene Ther Clin Dev; 2014 Mar; 25(1):1-6. PubMed ID: 24649836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making.
    Coppens DGM; de Wilde S; Guchelaar HJ; De Bruin ML; Leufkens HGM; Meij P; Hoekman J
    Cytotherapy; 2018 Jun; 20(6):769-778. PubMed ID: 29730080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.